Literature DB >> 3510879

Reversal of transformed phenotype by monoclonal antibodies against Ha-ras p21 proteins.

H F Kung, M R Smith, E Bekesi, V Manne, D W Stacey.   

Abstract

The transforming activities of p21 ras proteins have been determined by micro-injection of these proteins into NIH3T3 cells. In order to facilitate functional studies on the effect of ras proteins on malignant transformation and normal cellular growth, analysis has been made with three monoclonal antibodies (YA6-172, Y13-238 and Y13-259) as originally reported by Furth et al. (J virol 43 (1982) 294). Purified immunoglobulin of Y13-259 has the highest titer of binding to bacterially synthesized p21 ras proteins. Experimental analyses indicate that only Y13-259 antibody will neutralize the transforming activity of the co-injected bacterially synthesized ras protein and the neutralization effect was blocked by co-injection of excess ras protein. In addition, micro-injection of Y13-259 immunoglobulin into transformed NIH3T3 cells (obtained by DNA transfection of NIH3T3 cells with molecularly cloned ras gene) reversed their transformed phenotypes. These results indicate that both bacterially synthesized p21 ras proteins and the natural ras proteins produced in NIH3T3 cells were neutralized by Y13-259 antibody.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510879     DOI: 10.1016/0014-4827(86)90341-1

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  A transforming ras gene can provide an essential function ordinarily supplied by an endogenous ras gene.

Authors:  A G Papageorge; B M Willumsen; M Johnsen; H F Kung; D W Stacey; W C Vass; D R Lowy
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  Antibodies to synthetic peptide from the residue 33 to 42 domain of c-Ha-ras p21 block reconstitution of the protein with different effectors.

Authors:  I Rey; P Soubigou; L Debussche; C David; A Morgat; P E Bost; J F Mayaux; B Tocque
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

Review 3.  Targeting Ras with Macromolecules.

Authors:  Dehua Pei; Kuangyu Chen; Hui Liao
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

4.  Induction of neurite formation in PC12 cells by microinjection of proto-oncogenic Ha-ras protein preincubated with guanosine-5'-O-(3-thiotriphosphate).

Authors:  T Satoh; S Nakamura; Y Kaziro
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

Review 5.  The Ras signal transduction pathway.

Authors:  R Khosravi-Far; C J Der
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

6.  The roles of phospholipase D and a GTP-binding protein in guanosine 5'-[gamma-thio]triphosphate-stimulated hydrolysis of phosphatidylcholine in rat liver plasma membranes.

Authors:  K M Hurst; B P Hughes; G J Barritt
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

7.  Novel monoclonal antibodies that differentiate between the binding of pp60c-src or protein phosphatase 2A by polyomavirus middle T antigen.

Authors:  S M Dilworth; V P Horner
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Ras signaling in the activation of glucose transport by insulin.

Authors:  J Manchester; X Kong; O H Lowry; J C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Insulin induction of Xenopus laevis oocyte maturation is inhibited by monoclonal antibody against p21 ras proteins.

Authors:  A K Deshpande; H F Kung
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

10.  Expression of Ha-ras oncogene p21 protein in relation to the cell cycle of cultured human tumor cells.

Authors:  B Czerniak; F Herz; R P Wersto; L G Koss
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.